Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Anti-TFPI Aptamer Technology
Anti-TFPI Aptamer Technology
Baxter Announces Acquisition of All Hemophilia-Related Assets of Archemix and an Exclusive License of Its Anti-TFPI Aptamer Technology
Fri, 11/19/10 - 03:00 pm
Baxter International
Archemix
hemophilia
Anti-TFPI Aptamer Technology
